Lethality among individuals infected with visceral leishmaniasis in Brazil: a retrospective study (2007–2018)

被引:0
作者
Luciana Silami Carvalho
Maria das Graças Braga
Dário Alves da Silva Costa
Taynãna César Simões
Mariana Dias Lula
Micheline Rosa Silveira
机构
[1] Federal University of Minas Gerais,Social Pharmacy Department, Faculty of Pharmacy
[2] René Rachou Institute,undefined
[3] Fiocruz Minas Gerais,undefined
来源
Parasitology Research | 2022年 / 121卷
关键词
Visceral leishmaniasis; HIV; Prevalence; Lethality; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
Visceral leishmaniasis (VL) is a public health problem with a high prevalence and lethality in Brazil. This study aims to estimate the lethality and associated factors in individuals with VL and assess survival time, emphasizing VL/HIV coinfection. This retrospective study has 37,583 individuals notified and confirmed with VL in the Sistema de Informação de Agravos de Notificação (SINAN) between 2007 and 2018 (Brazil). Lethality was evaluated considering VL deaths, deaths from other causes (OC), and non-deaths. We performed a multinomial logistic regression, with non-death as the benchmark category. We conducted a survival analysis (Kaplan–Meier method), emphasizing VL/HIV coinfection. Most individuals were young, male, mixed race, low schooling level, and urban dwellers. The lethality rate was 10.2% (VL and OC deaths) and 7.8% (VL deaths). The prevalence of HIV infection was 8.81%. A higher likelihood of VL and OC deaths was observed in older age groups, females, and with a higher number of symptoms. A higher likelihood of OC deaths was identified in individuals with HIV. A lower likelihood of VL and OC deaths was observed for individuals on VL therapy. The mean survival time was longer for VL/HIV individuals, who had a lower survival rate than those with VL. The data point to the need for attention to the timely diagnosis of VL and HIV and adequate pharmacological treatment in this population.
引用
收藏
页码:725 / 736
页数:11
相关论文
共 46 条
[1]  
Abreu MS(2021)Aspectos epidemiológicos e distribuição espacial da leishmaniose visceral em Picos, Piauí, Brasil Saúde Coletiva (Barueri) 11 5846-5857
[2]  
Siqueira JMMT(2016)(2016) Trend in cumulative cases and mortality rate among visceral leishmaniasis patients in Eastern Sudan: a 14-year registry, 2002–2015 Int J Infect Dis 51 81-84
[3]  
Maia JCS(2021)Visceral Leishmaniasis and Human Immunodeficiency Virus Coinfection: epidemiological profile of cases reported in São Luís-Maranhão, Brazil Res Soc Dev 10 e2310413317-11
[4]  
Adam GK(2012)The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis PLoS Negl Trop Dis 6 01-349
[5]  
Ali KM(2021)Inequalities of visceral leishmaniasis case-fatality in Brazil: A multilevel modeling considering space, time, individual and contextual factors PLoS Negl Trop Dis 15 e0009567-21
[6]  
Abdella YH(2021)Reativação de leishmaniose visceral (LV) em pacientes imunodeprimidos por HIV: Relato de caso e revisão de literatura The Brazilian Journal of Infections Diseases 25 S1-201
[7]  
Costa RKE(2004)Leishmaniose visceral no Brasil: quadro atual, desafios e perspectivas Rev Bras Epidemiol 7 338-939
[8]  
Holanda EC(2013)Leishmaniose visceral: aspectos epidemiológicos relacionados aos óbitos em Mossoró-RN J Trop Pathol 42 10-04
[9]  
Andrade SM(2018)Changing demographics of visceral leishmaniasis in northeast Brazil: lessons for the future PLoS Negl Trop Dis 12 e0006164-27
[10]  
Cota GF(2018)Visceral leishmaniasis and HIV coinfection: current perspectives HIV/AIDS-Res Palliat Care 10 193-526